The platform compresses a slow, expensive, expert-dependent process into a minutes-long automated workflow — without sacrificing the precision regulators demand. Claude AI runs under a 185-rule pharmaceutical prompt with anti-hallucination safeguards; a multi-pass QA stage combines LLM validation with deterministic correction; and OOXML processing preserves the exact document structure while converting Hebrew RTL to English LTR. The result is regulatory-ready English PILs faithful to the source in meaning, terminology and formatting.






